Proposal
Proposal
ResearchHub Logo
Home
My Funding
Peer Review
Journal

Drafts

Plasma Phospho-Tau Epitope Signatures Resolved by Simoa D... | ResearchHub
Proposal
Proposal
ResearchHub Logo
Home
My Funding
Peer Review
Journal

Drafts

Fundraise closed
0
Dr. Alireza Nourazarian (PhD)

Dr. Alireza Nourazarian (PhD)

Plasma Phospho-Tau Epitope Signatures Resolved by Simoa Discriminate PSP, CBD, and Alzheimer's Disease in a Multicenter Cohort

Dr. Alireza Nourazarian (PhD)
Dr. Alireza Nourazarian (PhD)
Dr. Alireza Nourazarian (PhD)

Clinical Neurochemistry Fellowship

Posted Jun 22, 2026Neurodevelopmental and neuropsychiatric conditionsDOI
Funding· Closed

$32of $10,000

0%

Submitted to

Neurodevelopmental and neuropsychiatric conditionsResearchHub Foundation

Reviewed by2

Key insightsBeta

Multicenter observational study proposing a 5-epitope plasma phospho-tau Simoa panel plus NfL/GFAP to distinguish PSP, CBD/CBS, AD, and controls (n=480) over 36 months, with pre-registered analyses and open data. Rigorous design and QC scaffolding are strengths, but the $10,000 single-site pilot budget cannot fund the described multicenter study, and the topic does not fit the RFP's neurodevelopmental/neuropsychiatric scope.

  • Rigorous Preregistration
  • Clinically Important Question
  • Budget Scope Mismatch
  • RFP Misalignment